Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)

BACKGROUND: To evaluate patient-reported outcomes with ramucirumab plus docetaxel, a regimen which improved progression-free survival in platinum-refractory advanced urothelial carcinoma (aUC). METHODS: RANGE—a randomized, double-blinded, phase 3 trial in patients with platinum-refractory aUC. Ramuc...

詳細記述

保存先:
書誌詳細
出版年:BMC Urol
主要な著者: Necchi, Andrea, Nishiyama, Hiroyuki, Matsubara, Nobuaki, Lee, Jae-Lyun, Petrylak, Daniel P., de Wit, Ronald, Drakaki, Alexandra, Liepa, Astra M., Mao, Huzhang, Bell-McGuinn, Katherine, Powles, Thomas
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648381/
https://ncbi.nlm.nih.gov/pubmed/33160359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-020-00752-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料